US Stem Cell Inc (USRM)

[Dragon Lady]

"7% discount!!!!"

It's dilution, and it will be massive. How many shares, at 1.5 cents does it take to get a single $500K draw against that credit line? Further, why does one think Magna FIRST did a highly dilutive, $200K convertible note, with a $300K face value on it? Why that one first? If one would look up the history of Magna and how they "do what they do" it would all be clear as a bell. Magna has a long and well established reputation of being a share price crusher. Just read some of the I-HUB forums, created just to discuss Magna deals and what happened to the companies that took on their "financing programs", one being the very one BHRT signed up for, the "Enhanced equity line" blah, blah whatever it's called. Numerous posts and entire threads on companies and how rapidly their share price declined after using Magna for financing.

Why's the BHRT trading vol almost nothing right now, and the price is parked close to 1.5 cents in a sustained down-trend, when all the big news and "financing" and the 10-Q and all is already out? Why? What's the hold up? Makes no sense to me?

$500K/ (1.5 cents x .93) = 35 MILLION SHARES. Just that one draw would cause that much dilution, and that's not counting Asher, the Magna convertible deal, KBM, Fourth Man and Daniel James, all using convertible debt deals and still diluting, on-going as we speak.

Just this past qtr, they, BHRT diluted out about 45 MILLION shares in a single qtr. Wait till the Magna convertible note kicks in, and then they make the first draw or two on the Magna credit line. There's a reason they bumped the A/S to 2 BILLION, they're gonna bump into that 970 MILLION limit real quick at this rate, IMO (past 650 MILLION already). Easy. Less than 2 qtrs IMO.

And the money from that line- doesn't even cover the present cash short falls of this past 10-Q, it's not even remotely enough to fund a single, FDA level, phase II trial IMO. Notice, the verbiage about still "NEEDING FUNDING TO RE-START TRIALS" was right there as always, in this latest 10-Q filing. Right along side the Magna "financing" info.